polyglycolic acid

Summary

Summary: A biocompatible polymer used as a surgical suture material.

Top Publications

  1. ncbi Poly(D,L lactic-co-glycolic acid) microspheres as biodegradable microcarriers for pluripotent stem cells
    Kimberley D Newman
    Ottawa Regional Cancer Centre and Departments of Medicine, University of Ottawa, Ottawa, Ont, Canada K1H 1C4
    Biomaterials 25:5763-71. 2004
  2. ncbi Current advances in research and clinical applications of PLGA-based nanotechnology
    Jian ming Lu
    Michael E DeBakey Department of Surgery, Division of Vascular Surgery and Endovascular Therapy, Baylor College of Medicine, Houston, TX 77030, USA
    Expert Rev Mol Diagn 9:325-41. 2009
  3. ncbi Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation
    Fabienne Danhier
    Universite Catholique de Louvain, Unite de Pharmacie Galenique, Avenue Mounier, 73 20, 1200 Brussels, Belgium
    J Control Release 133:11-7. 2009
  4. ncbi The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices
    R A Jain
    NanoSystems, a Division of Elan Pharmaceutical Technologies, King of Prussia, PA 19406, USA
    Biomaterials 21:2475-90. 2000
  5. ncbi Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles
    Jayanth Panyam
    Department of Pharmaceutical Sciences, 986025 University of Nebraska Medical Center, Omaha, NE 68198-6025, USA
    J Control Release 92:173-87. 2003
  6. ncbi Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate
    Farnaz Esmaeili
    Novel Drug Delivery Systems Laboratory, Faculty of Pharmacy, Medical Sciences, University of Tehran, Tehran, Iran
    J Drug Target 16:415-23. 2008
  7. ncbi Porous poly(alpha-hydroxyacid)/Bioglass composite scaffolds for bone tissue engineering. I: Preparation and in vitro characterisation
    V Maquet
    Centre for Education and Research on Macromolecules, , Belgium
    Biomaterials 25:4185-94. 2004
  8. ncbi Controlled release of sirolimus from a multilayered PLGA stent matrix
    Xintong Wang
    School of Materials Science and Engineering, Nanyang Technological University, Singapore, Singapore
    Biomaterials 27:5588-95. 2006
  9. ncbi Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy
    Anindita Mukerjee
    Department of Molecular Biology, Institute for Cancer Research, Graduate School of Biomedical Sciences, University of North Texas, Health Science Center, Fort Worth, TX, 76107, USA
    Anticancer Res 29:3867-75. 2009
  10. ncbi Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells
    Murali Mohan Yallapu
    Cancer Biology Research Center, Sanford Research USD, Sioux Falls, SD 57105, USA
    J Colloid Interface Sci 351:19-29. 2010

Detail Information

Publications279 found, 100 shown here

  1. ncbi Poly(D,L lactic-co-glycolic acid) microspheres as biodegradable microcarriers for pluripotent stem cells
    Kimberley D Newman
    Ottawa Regional Cancer Centre and Departments of Medicine, University of Ottawa, Ottawa, Ont, Canada K1H 1C4
    Biomaterials 25:5763-71. 2004
    ..More importantly, our study demonstrates the potential use of PLGA microspheres as transplantation matrices of pluripotent stem cells for tissue engineering and regeneration...
  2. ncbi Current advances in research and clinical applications of PLGA-based nanotechnology
    Jian ming Lu
    Michael E DeBakey Department of Surgery, Division of Vascular Surgery and Endovascular Therapy, Baylor College of Medicine, Houston, TX 77030, USA
    Expert Rev Mol Diagn 9:325-41. 2009
    ....
  3. ncbi Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation
    Fabienne Danhier
    Universite Catholique de Louvain, Unite de Pharmacie Galenique, Avenue Mounier, 73 20, 1200 Brussels, Belgium
    J Control Release 133:11-7. 2009
    ..Therefore, PTX-loaded nanoparticles may be considered as an effective anticancer drug delivery system for cancer chemotherapy...
  4. ncbi The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices
    R A Jain
    NanoSystems, a Division of Elan Pharmaceutical Technologies, King of Prussia, PA 19406, USA
    Biomaterials 21:2475-90. 2000
    ..Also, certain issues about other related biodegradable polyesters are discussed...
  5. ncbi Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles
    Jayanth Panyam
    Department of Pharmaceutical Sciences, 986025 University of Nebraska Medical Center, Omaha, NE 68198-6025, USA
    J Control Release 92:173-87. 2003
    ..1 microm) as compared to the larger-size microparticles could explain some of the observed degradation results with different size particles...
  6. ncbi Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate
    Farnaz Esmaeili
    Novel Drug Delivery Systems Laboratory, Faculty of Pharmacy, Medical Sciences, University of Tehran, Tehran, Iran
    J Drug Target 16:415-23. 2008
    ..These results suggested that FOL-targeted DTX NPs could be a potentially useful delivery system for FOL-receptor-positive cancer cells...
  7. ncbi Porous poly(alpha-hydroxyacid)/Bioglass composite scaffolds for bone tissue engineering. I: Preparation and in vitro characterisation
    V Maquet
    Centre for Education and Research on Macromolecules, , Belgium
    Biomaterials 25:4185-94. 2004
    ..Formation of hydroxyapatite on the surface of composites, as an indication of their bioactivity, was recorded by EDXA, X-ray diffractometry and confirmed by Raman spectroscopy...
  8. ncbi Controlled release of sirolimus from a multilayered PLGA stent matrix
    Xintong Wang
    School of Materials Science and Engineering, Nanyang Technological University, Singapore, Singapore
    Biomaterials 27:5588-95. 2006
    ..The release of sirolimus can, on the other hand, be retarded by using a coating of a biodegradable polyester with a lauryl ester end group. Therefore, multilayered systems offer many options for controlling sirolimus release over months...
  9. ncbi Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy
    Anindita Mukerjee
    Department of Molecular Biology, Institute for Cancer Research, Graduate School of Biomedical Sciences, University of North Texas, Health Science Center, Fort Worth, TX, 76107, USA
    Anticancer Res 29:3867-75. 2009
    ..Our present work investigated the efficiency of encapsulation of curcumin in poly (lactic-coglycolic acid) (PLGA) nanospheres using solid/oil/water emulsion solvent evaporation method...
  10. ncbi Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells
    Murali Mohan Yallapu
    Cancer Biology Research Center, Sanford Research USD, Sioux Falls, SD 57105, USA
    J Colloid Interface Sci 351:19-29. 2010
    ....
  11. ncbi Chemical degradation of peptides and proteins in PLGA: a review of reactions and mechanisms
    M L Houchin
    Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas, USA
    J Pharm Sci 97:2395-404. 2008
    ..This review summarizes the peptide/protein chemical degradation reactions that have been reported in PLGA systems and their mechanisms. Reported methods for stabilizing peptides and proteins in PLGA devices are also discussed...
  12. ncbi PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination
    Marie Garinot
    Universite Catholique de Louvain, Unite de Pharmacie Galenique, Brussels, Belgium
    J Control Release 120:195-204. 2007
    ..Finally, ovalbumin-loaded nanoparticles were orally administrated to mice and induced an IgG response, attesting antigen ability to elicit an immune response after oral delivery...
  13. ncbi Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro
    M A Tracy
    Alkermes Inc, Cambridge, MA 02139, USA
    Biomaterials 20:1057-62. 1999
    ..Finally, zinc carbonate was found to retard the degradation of some PLGs. These degradation studies have proved valuable in the design of sustained release microsphere products...
  14. ncbi Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo
    G Mittal
    Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, S A S Nagar, Punjab, India
    J Control Release 119:77-85. 2007
    ..Together, these results indicate that nanoparticulate formulations are ideal carriers for oral administration of estradiol having great potential to address the dose related issues of estradiol...
  15. ncbi A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS
    L Mu
    Division of Bioengineering, The National University of Singapore, 9 Engineering Drive 1, 117576, Singapore, Singapore
    J Control Release 86:33-48. 2003
    ..Nanoparticles of nanometer size with narrow distribution can be obtained. A drug encapsulation efficiency as high as 100% can be achieved and the release kinetics can be controlled...
  16. ncbi Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance
    Yogesh Patil
    Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA
    J Control Release 136:21-9. 2009
    ..Taken together, these results suggest that the use of targeted, dual agent nanoparticles delivering a combination of P-gp modulator and anticancer drug is a very promising approach to overcome tumor drug resistance...
  17. ncbi Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66
    J E Rosas
    Pharmacy and Pharmaceutical Technology Laboratory, Pharmacy Faculty, University of the Basque Country (UPV-EHU, Paseo de la Universidad no.7, 01006, Vitoria-Gasteiz, Spain
    Vaccine 19:4445-51. 2001
    ..These observations illustrate the potential of PLGA microspheres as a delivery system for chemically synthesised antigens...
  18. ncbi Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone
    J L Italia
    Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 27 Taylor Street, Glasgow, UK
    Pharm Res 26:1324-31. 2009
    ..3%) and severe nephrotoxicity, was entrapped into poly(lactide-co-glycolide) (PLGA) nanoparticles to improve the oral bioavailability and to minimize the adverse effects associated with it...
  19. ncbi Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses
    Manish Diwan
    Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada
    J Drug Target 11:495-507. 2003
    ..0005). These results indicate that PLGA nanoparticles mimicking certain features of pathogens are efficient delivery systems for targeting vaccine antigens to DCs and activation of potent T cell responses...
  20. ncbi Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles
    Jayanth Panyam
    Department of Pharmaceutical Sciences, University of Nebraska Medical Center, 986025, Omaha, Nebraska 68198, USA
    J Pharm Sci 93:1804-14. 2004
    ..In conclusion, the solid-state drug-polymer solubility affects the nanoparticle characteristics, and thus could be used as an important preformulation parameter...
  21. ncbi Periodontal delivery of ipriflavone: new chitosan/PLGA film delivery system for a lipophilic drug
    P Perugini
    Department of Pharmaceutical Chemistry, University of Pavia, V le Taramelli 12, 27100, Pavia, Italy
    Int J Pharm 252:1-9. 2003
    ..In vitro experiments demonstrated that the composite micromatricial films represent a suitable dosage form to prolong ipriflavone release for 20 days...
  22. ncbi Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity
    Cristina Fonseca
    Center for Neuroscience and Cell Biology of Coimbra, University of Coimbra, 3000, Coimbra, Portugal
    J Control Release 83:273-286. 2002
    ..Our results demonstrate that incorporation of Ptx in nanoparticles strongly enhances the cytotoxic effect of the drug as compared to Taxol, this effect being more relevant for prolonged incubation times...
  23. ncbi Anti-cancer drug diffusion within living rat brain tissue: an experimental study using [3H](6)-5-fluorouracil-loaded PLGA microspheres
    Valérie Gaëlle Roullin
    INSERM ERIT M 0104, Angers, France
    Eur J Pharm Biopharm 53:293-9. 2002
    ..Results show that an important microparticle backflow occurs in healthy rats, whereas the microspheres remain at the site of administration in C6 glioma-bearing rats. Drug diffusion is limited to the vicinity of the implantation site...
  24. ncbi Preparation and in vitro anticancer activity of wheat germ agglutinin (WGA)-conjugated PLGA nanoparticles loaded with paclitaxel and isopropyl myristate
    Yun Mo
    Department of Pharmacy, National University of Singapore, 18 Science Drive 4, 117543, Singapore
    J Control Release 107:30-42. 2005
    ..WIT-NP exhibited stronger cell-killing effect because of more efficient cellular uptake via WGA-receptor-mediated endocytosis and IPM-facilitated release of paclitaxel from the NPs...
  25. ncbi Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells
    Evangelos C Gryparis
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Patras, Rio, Greece
    Eur J Pharm Biopharm 67:1-8. 2007
    ....
  26. ncbi Doxorubicin release from core-shell type nanoparticles of poly(DL-lactide-co-glycolide)-grafted dextran
    Young-Il Jeong
    The Research Institute of Medical Sciences, Chonnam National University, Gwangju, Korea
    Arch Pharm Res 29:712-9. 2006
    ..Core-shell type nanoparticles of DexLG copolymer can be used as a colonic drug carrier. In conclusion, size, morphology, and molecular structure of DexLG nanoparticles are available to consider as an oral drug targeting nanoparticles...
  27. ncbi Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer
    Bingfeng Sun
    Division of Bioengineering, National University of Singapore, Block E3A, 04 15, 7 Engineering Drive 1, Singapore 117574, Singapore
    Biomaterials 29:475-86. 2008
    ..Judged by IC50 after 24h culture, the therapeutic effects of the drug formulated in the NPs with surface decoration could be 12.74 times higher than that of the bare NPs and 13.11 times higher than Taxol...
  28. ncbi Preparation and characterization of cationic PLGA nanospheres as DNA carriers
    M N V Ravi Kumar
    Department of Biopharmaceutics and Pharmaceutical Technology, Saarland University, D 66123, Saarbrucken, Germany
    Biomaterials 25:1771-7. 2004
    ..These cationic PLGA nanospheres could serve as potential alternatives of the existing negatively charged nanoparticles...
  29. ncbi Synthesis and characterization of PLGA nanoparticles
    Carlos E Astete
    Department of Biological and Agricultural Engineering, Louisiana State University Agricultural Center, Baton Rouge 70803, USA
    J Biomater Sci Polym Ed 17:247-89. 2006
    ....
  30. ncbi Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells
    Praveen Elamanchili
    Faculty of Pharmacy and Pharmaceutical Sciences, 3118 Dentistry/Pharmacy Centre, University of Alberta, Edmonton, Alberta, Canada T6G 2N8
    Vaccine 22:2406-12. 2004
    ..These results strongly suggest that PLGA nanoparticles provide an efficient vaccine delivery system for targeting DCs and the development of DC based cellular vaccines...
  31. ncbi Use of nanoparticles for cerebral cancer
    Jorg Kreuter
    Institute for Pharmaceutical Technology, Johann Wolfgang Goethe University, Frankfurt Main, Germany
    Tumori 94:271-7. 2008
    ....
  32. ncbi Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics
    K Derakhshandeh
    Department of Pharmaceutics, School of Pharmacy, Shaheed Beheshti Medical University, Tehran, Iran
    Eur J Pharm Biopharm 66:34-41. 2007
    ..Thus prepared nanoparticles described here may be of clinical importance in both stabilizing and delivering camptothecins for cancer treatment...
  33. ncbi G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method
    Seung Ho Choi
    Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 305-701, South Korea
    Int J Pharm 311:223-8. 2006
    ..Reversed phase and size exclusion chromatograms revealed that the structural integrity of released rhG-CSF from nanoparticles was nearly intact, compared to that of native rhG-CSF...
  34. ncbi Design of a multifunctional PLGA nanoparticulate drug delivery system: evaluation of its physicochemical properties and anticancer activity to malignant cancer cells
    Zhe Wang
    Department of Pharmacy, National University of Singapore, 18 Science Drive 4, Singapore, 117543, Singapore
    Pharm Res 26:1162-71. 2009
    ..Several individual approaches were combined to fabricate a novel nanoparticulate drug delivery system to achieve targeting and anticancer effects in various malignant cancer cells...
  35. ncbi Tendon-bone insertion repair and regeneration using polyglycolic acid sheet in the rabbit rotator cuff injury model
    Shin Yokoya
    Department of Orthopaedic Surgery, Programs for Applied Biomedicine, Division of Clinical Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan
    Am J Sports Med 36:1298-309. 2008
    ..The quality of tendons has considerable limitations regarding torn rotator cuff tendons. Tissue-engineering techniques using a biodegradable scaffold offer potential alternatives for recreating a valid tendon-to-bone interface...
  36. ncbi Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles
    Farnaz Esmaeili
    Novel Drug Delivery Systems Lab, Pharmaceutics Department, Faculty of Pharmacy, Medical Sciences, University of Tehran, Tehran, Iran
    Nanomedicine 3:161-7. 2007
    ..The effect of nanoencapsulation of RIF on the antibacterial activity of RIF against gram-positive and gram-negative bacteria was evaluated. It was shown that RIF NPs could considerably improve the RIF antibacterial efficacy...
  37. ncbi Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers
    Biswajit Mukherjee
    Department of Pharmaceutical Technology, Jadavpur University, Kolkata, West Bengal, India
    Int J Nanomedicine 3:487-96. 2008
    ..Decreased (10,000 rpm) or enhanced (24,000 rpm) homogenizing speeds resulted in increased polydispersion with larger particles having no better protein-loading and -release profiles in the present study...
  38. ncbi PLGA nanoparticles in drug delivery: the state of the art
    Indu Bala
    Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER, Punjab, India
    Crit Rev Ther Drug Carrier Syst 21:387-422. 2004
    ..Careful design of these delivery systems with respect to target and route of administration may solve some of the problems faced by new classes of active molecules...
  39. ncbi Structure formation in injectable poly(lactide-co-glycolide) depots
    Liwei Wang
    School of Materials Engineering, Nanyang Technological University, N4.1-1-30 Nanyang Avenue, 639798 Singapore
    J Control Release 90:345-54. 2003
    ..Extent of degradation and gelation of PLGA were shown to depend on the solvent...
  40. ncbi PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution
    Farnaz Esmaeili
    Novel Drug Delivery Systems Laboratory, Department of Pharmaceutics, Faculty of Pharmacy, Medical Sciences University of Tehran, P O Box 14155 6451, Tehran, Iran
    Int J Pharm 349:249-55. 2008
    ....
  41. ncbi Hydrolytic degradation characteristics of irradiated multi-layered PLGA films
    Say Chye Joachim Loo
    School of Materials Science and Engineering, Nanyang Technological University, 50 Nanyang Avenue, Singapore 639798, Singapore
    Int J Pharm 360:228-30. 2008
    ..Also, the erosion of the top layer, of this multi-layered structure, accelerates degradation of the underlying layers. It is this effect that results in the observed pseudo-surface erosion for irradiated multi-layered PLGA...
  42. ncbi Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems
    Xiaosong Luan
    College of Pharmacy, , Kelchstr. 31, 12169 Berlin, Germany
    J Control Release 110:266-72. 2006
    ..6-month controlled release leuprolide ISM could be obtained by blending poly(lactides) (PLA) with different molecular weights...
  43. ncbi The effect of mesoporous bioactive glass on the physiochemical, biological and drug-release properties of poly(DL-lactide-co-glycolide) films
    Chengtie Wu
    Biomaterials and Tissue Engineering Research Unit, School of AMME, The University of Sydney, Sydney 2006, Australia
    Biomaterials 30:2199-208. 2009
    ....
  44. ncbi Do in situ forming PLG/NMP implants behave similar in vitro and in vivo? A non-invasive and quantitative EPR investigation on the mechanisms of the implant formation process
    Sabine Kempe
    Pharmaceutics and Biopharmaceutics Division, Institute of Pharmacy, Martin Luther University Halle Wittenberg, Halle 06120, Germany
    J Control Release 130:220-5. 2008
    ..The replacement of the organic solvent NMP by water was determined by polarity shifts within the implant and could be quantified. Both the kinetic of NMP-water exchange and polymer precipitation showed good in vitro-in vivo correlation...
  45. ncbi Compositional effects on the formation of a calcium phosphate layer and the response of osteoblast-like cells on polymer-bioactive glass composites
    Helen H Lu
    Biomaterials and Interface Tissue Engineering Laboratory, Department of Biomedical Engineering, Columbia University, 351 Engineering Terrace Building, MC 8904, 1210 Amsterdam Avenue, New York, NY 10027, USA
    Biomaterials 26:6323-34. 2005
    ..The results of this study suggest that there is a threshold BG content which is optimal for osteoblast growth, and the interactions between PLAGA and BG may modulate the kinetics of Ca-P formation and the overall cellular response...
  46. ncbi Effect of drug type on the degradation rate of PLGA matrices
    Steven J Siegel
    Stanley Center for Experimental Therapeutics, Department of Psychiatry, University of Pennsylvania, Philadelphia, USA
    Eur J Pharm Biopharm 64:287-93. 2006
    ..We conclude that the design of biodegradable polymeric drug carriers with high drug loadings must account for the effect of the drug on the polymer degradation and drug release rate...
  47. ncbi In vitro and in vivo degradation of poly(L: -lactide-co-glycolide) films and scaffolds
    Elzbieta Pamula
    Department of Biomaterials, Faculty of Materials Science and Ceramics, AGH University of Science and Technology, Al Mickiewicza 30, Krakow 30 059, Poland
    J Mater Sci Mater Med 19:2063-70. 2008
    ..In the scaffolds, having much thinner pore walls, heterogenous degradation due to the autocatalytic effect was not observed...
  48. ncbi Controlled release from bioerodible polymers: effect of drug type and polymer composition
    Alexis Frank
    School of Materials Engineering, N4.1-1-30, Nanyang Technological University, Nanyang Avenue, Singapore 639798, Singapore
    J Control Release 102:333-44. 2005
    ..4). The details of the study of different factors influencing the drug release may have important implications for the control of delivery of potent drugs in various therapeutic windows...
  49. ncbi The effect of bioactive glass content on synthesis and bioactivity of composite poly (lactic-co-glycolic acid)/bioactive glass substrate for tissue engineering
    Jun Yao
    Department of Bioengineering, Center for Bioactive Materials and Tissue Engineering, University of Pennsylvania, 3401 Walnut Street, Philadelphia, PA 19104, USA
    Biomaterials 26:1935-43. 2005
    ..This porous scaffold supported both MSC proliferation and promoted MSC differentiation into cells expressing the osteoblast phenotype. It therefore demonstrates significant potential as a bone replacement material...
  50. ncbi Poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy
    Yuancai Dong
    Department of Chemical and Biomolecular Engineering, National University of Singapore, Block E5, 02 11, 4 Engineering Drive 4, Singapore 117576, Singapore
    Int J Pharm 342:208-14. 2007
    ..The freeze-dried nanoparticles were found to possess excellent water redispersability. The high pressure homogenization could be applied for large industrial scale production of nanoparticles for drug delivery...
  51. ncbi Characterization of perivascular poly(lactic-co-glycolic acid) films containing paclitaxel
    John K Jackson
    Faculty of Pharmaceutical Sciences, University of British Columbia, 2146 East Mall, Vancouver, BC, Canada V6T 1Z3
    Int J Pharm 283:97-109. 2004
    ..PLGA films containing 30% diblock and either 1% or 5% paclitaxel were partially or completely degraded following perivascular implantation in rats...
  52. ncbi Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitro
    A Fernandez-Carballido
    Departamento de Farmacia y Tecnologia Farmaceutica, Facultad de Farmacia, Avda Complutense s n, Universidad Complutense, 28040 Madrid, Spain
    Int J Pharm 279:33-41. 2004
    ..Labrafil modulates the release rate of donor-acceptor substances such as ibuprofen...
  53. ncbi Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting
    Tarek M Fahmy
    Department of Biomedical Engineering, Yale University, PO Box 208284, New Haven, CT 06520, USA
    Biomaterials 26:5727-36. 2005
    ..Because of its ease, generality and flexibility, this strategy promises widespread utility in modifying the surface of PLGA-based materials for applications in drug delivery and tissue engineering...
  54. ncbi Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer
    Magali Zeisser-Labouèbe
    Department of Pharmaceutics and Biopharmaceutics, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, 30 quai E Ansermet, CH 1211 Geneva 4, Switzerland
    Int J Pharm 326:174-81. 2006
    ..The influence of NP drug loading on the Hy release from NPs was also investigated...
  55. ncbi Controlled delivery of aspirin: effect of aspirin on polymer degradation and in vitro release from PLGA based phase sensitive systems
    Yu Tang
    Department of Pharmaceutical Sciences, College of Pharmacy, Nursing, and Allied Sciences, North Dakota State University, Fargo, ND 58105, USA
    Int J Pharm 357:119-25. 2008
    ..These findings suggest that aspirin causes an unusually faster degradation of PLGA. Such faster degradation of PLGA has not been noticed for any other drugs reported in the literature...
  56. ncbi PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid
    Lucia Bondioli
    Department of Pharmaceutical Sciences, University of Modena and RE, Modena, Italy
    Biomaterials 31:3395-403. 2010
    ..Thus, the new Neu5Ac-modified PLGA polyester represent a useful starting material for the preparation of NPs surface decorated with this sialic acid...
  57. ncbi Therapeutic effect of in vivo sustained estradiol release from poly (lactide-co-glycolide) microspheres on bone mineral density of osteoporosis rats
    Makoto Otsuka
    Department of Pharmaceutical Technology, Kobe Pharmaceutical University, Motoyama Kitamachi 4 19 1, Higashi Nada, Kobe 658 8558, Japan
    Biomed Mater Eng 12:157-67. 2002
    ..This suggested that all estradiol microspheres administration induced bone generation in osteoporosis rats...
  58. ncbi Thermally-triggered gelation of PLGA dispersions: towards an injectable colloidal cell delivery system
    Michael R Fraylich
    Biomaterial Science Group, School of Materials, The University of Manchester, Grosvenor Street, Manchester M17HS, UK
    J Colloid Interface Sci 344:61-9. 2010
    ..The results suggest that this general family of biodegradable thermogelling PLGA dispersions, introduced here for the first time, may have longer-term application as an injectable colloidal cell delivery system...
  59. ncbi Porous polymer/hydroxyapatite scaffolds: characterization and biocompatibility investigations
    Timothy Douglas
    Department of Oral and Maxillofacial Surgery, University of Kiel, Arnold Heller Strasse 16, 24105, Kiel, Germany
    J Mater Sci Mater Med 20:1909-15. 2009
    ..It was shown that PLGA-HAP composites support osteoblast growth and vitality, paving the way for applications as bone tissue engineering scaffolds...
  60. ncbi Drug release from PLGA-based microparticles: effects of the "microparticle:bulk fluid" ratio
    D Klose
    College of Pharmacy, JE 2491, Univ Lille Nord de France, 3 Rue du Prof Laguesse, 59006 Lille, France
    Int J Pharm 383:123-31. 2010
    ..This should be carefully taken into account when defining the experimental conditions for drug release measurements from this type of advanced drug delivery systems...
  61. ncbi Potential applications of PLGA film-implants in modulating in vitro drugs release
    María Jesús Dorta
    Dpto Ingeniería Química y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de La Laguna, 38200 Tenerife, Spain
    Int J Pharm 248:149-56. 2002
    ..The results show the suitability of the proposed devices to control release and avoid the burst effect with highly water-soluble drugs; as well as modulate in vitro peptide release...
  62. ncbi Parameters affecting the efficacy of a sustained release polymeric implant of leuprolide
    H B Ravivarapu
    Atrix Laboratories, Incorporated, 2579 Midpoint Drive, Fort Collins, CO 80525, USA
    Int J Pharm 194:181-91. 2000
    ..However, employing lower molecular weight polymer decreased the duration of efficacy of the formulation...
  63. ncbi Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: results with an acute dog model
    C Song
    Department of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, USA
    J Control Release 54:201-11. 1998
    ..5 +/- 3.5 to 83.7 +/- 1.4 micrograms/10 mg). Thus, the results support the view that modified nanoparticles along with optimized infusion conditions could enhance arterial wall drug concentrations of agents to treat restenosis...
  64. ncbi Preparation of bovine serum albumin loaded poly (D, L-lactic-co-glycolic acid) microspheres by a modified phase separation technique
    J X Zhang
    Zhejiang University, Hanzhou, PR China
    J Microencapsul 22:117-26. 2005
    ..GC analysis demonstrated that residual solvent of DCM and petroleum ether was decreased dramatically in comparison with PDMS used as a conventional coacervating agent...
  65. ncbi Effect of additives on encapsulation efficiency, stability and bioactivity of entrapped lysozyme from biodegradable polymer particles
    C Srinivasan
    National Institute of Immunolgy, Aruna Asaf Ali Marg, New Delhi, India
    J Microencapsul 22:127-38. 2005
    ..Use of RSA, sucrose and NaHCO3 helped in a co-operative way towards the formulation of particles entrapping bioactive lysozyme...
  66. ncbi Gas foamed open porous biodegradable polymeric microspheres
    Taek Kyoung Kim
    Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 305-701, South Korea
    Biomaterials 27:152-9. 2006
    ..These porous scaffold microspheres could be potentially utilized for cultivating cells in a suspension manner and for delivering the seeded cells to the tissue defect site in an injectable manner...
  67. ncbi Neurotrophin releasing single and multiple lumen nerve conduits
    Yang Yang
    Department of Chemical and Biological Engineering, Northwestern University, 2145 Sheridan Rd E156, Evanston, IL 60208-3120, USA
    J Control Release 104:433-46. 2005
    ..Polymer conduits with controllable lumen diameters and protein release may enhance nerve regeneration by guiding and stimulating neurite outgrowth...
  68. ncbi Preparation and characterization of biodegradable urea-loaded microparticles as an approach for transdermal delivery
    Azita Haddadi
    School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services, Tehran, Iran
    J Microencapsul 23:698-712. 2006
    ..87% +/- 5.3 and 40.5% +/- 3.4, respectively. The release study from PLGA microspheres revealed that up to 70% of the drug was released within a few days, through a four-stage release pattern...
  69. ncbi Physicochemical characterization of photopolymerizable PLGA blends
    Biancamaria Baroli
    Dipartimento Farmaco Chimico Tecnologico, University of Cagliari, Cagliari, Sardinia, Italy
    Adv Exp Med Biol 585:183-96. 2006
  70. ncbi Immune responses in mice of beta-galactosidase adsorbed or encapsulated in poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres
    N Stivaktakis
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Patras, Rion, Greece
    J Biomed Mater Res A 73:332-8. 2005
    ..Also, the type of polymer used to prepare the microspheres, but not the method of protein association with the microspheres, may affect the type of immune response...
  71. ncbi Effects of alginate coated on PLGA microspheres for delivery tetracycline hydrochloride to periodontal pockets
    D Z Liu
    Graduate Institute of Biomedical Materials, Taipei Medical University, Taipei, Taiwan, ROC
    J Microencapsul 21:643-52. 2004
    ..In conclusion, alginate coated Tc loaded PLGA microspheres could enhance Tc delivery to periodontal pocket by enhancing drug encapsulated efficiency, released quantities and sustained release period compared with uncoated ones...
  72. ncbi Controlled delivery of a hydrophilic drug from a biodegradable microsphere system by supercritical anti-solvent precipitation technique
    S Lee
    National Research Lab of Pharmaceutical Technology, College of Pharmacy, Chungnam National University, Daejeon, Korea
    J Microencapsul 23:741-9. 2006
    ....
  73. ncbi Biodegradable micro- and nanoparticles as long-term delivery vehicles for gentamicin
    Concepcion Lecaroz
    Department of Microbiology, University of Navarra, Pamplona, Spain
    J Microencapsul 23:782-92. 2006
    ..In summary, microspheres made of 502H, 503H and 75:25H and nanoparticles of 502H showed the best potential properties for systemic use in the treatment of intra-cellular gentamicin-susceptible pathogens...
  74. ncbi Polymeric delivery of proteins and plasmid DNA for tissue engineering and gene therapy
    T P Richardson
    Department of Biomedical Engineering, University of Michigan, Ann Arbor 48109, USA
    Crit Rev Eukaryot Gene Expr 11:47-58. 2001
    ....
  75. ncbi Enhanced immune response with a combination of alum and biodegradable nanoparticles containing tetanus toxoid
    R J Raghuvanshi
    National Institute of Immunology, New Delhi 110 067, India
    J Microencapsul 18:723-32. 2001
    ..Nanoparticles containing tetanus toxoid (TT) were formulated using a biodegradable polymer, polylactic polyglycolic acid co-polymer (50:50, molecular weight 100000)...
  76. ncbi Development of a cell transducible RhoA inhibitor TAT-C3 transferase and its encapsulation in biocompatible microspheres to promote survival and enhance regeneration of severed neurons
    Elaine Y M Tan
    Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Block MD9, 2 Medical Drive, Singapore 117597, Singapore
    Pharm Res 24:2297-308. 2007
    ..This study aims to circumvent these problems by developing a membrane-permeating form of C3 transferase and a biopolymer-based microsphere depot system for sustainable controlled release of the protein...
  77. ncbi Formulation, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres
    Vivek Ranjan Sinha
    University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India
    Drug Deliv 12:133-9. 2005
    ..From our study it as concluded that with careful selection of different polymers and their combinations, we can tailor the release of ketorolac tromethamine for long periods...
  78. ncbi Implantation of vancomycin microspheres in blend with human/rabbit bone grafts to infected bone defects
    Burcu Sayin
    Faculty of Pharmacy, Department of Pharmaceutical Technology, Hacettepe University, Ankara, Turkey
    J Microencapsul 23:553-66. 2006
    ....
  79. ncbi Therapeutic and toxicological evaluations of cyclosporine a microspheres as a treatment vehicle for uveitis in rabbits
    Yuan He
    Department of Ophthalmology, Peking University Third Hospital, Beijing, People's Republic of China
    J Ocul Pharmacol Ther 22:121-31. 2006
    ..CONCLUSIONS: The CsA-PLGA-MS preparation might be useful in the treatment of patients with severe chronic posterior uveitis who cannot tolerate systemic or periocular therapy...
  80. ncbi Influence of particle size and antacid on release and stability of plasmid DNA from uniform PLGA microspheres
    Neelesh K Varde
    Department of Chemical and Biomolecular Engineering, University of Illinois, 600 S Mathews Ave, Urbana, IL 61801 USA
    J Control Release 124:172-80. 2007
    ..Our studies show that the incorporation of antacid into the microsphere structure has potential in addressing some of the major problems associated with DNA encapsulation and release in PLGA microspheres...
  81. ncbi Formulation and statistical optimization of novel double-incorporated PLA-PLGA microparticles within an alginate-pectinate platform for the delivery of nicotine
    Neha Singh
    Department of Pharmacy and Pharmacology, University of the Witwatersrand, Parktown, South Africa
    J Microencapsul 23:153-67. 2006
    ..Although double incorporation continued to provide a burst effect, this was followed by a lag period for 7 days and a second phase of drug release...
  82. ncbi Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study
    Magharla Dasaratha Dhanaraju
    Department of Pharmaceutics, GIET School of Pharmacy, NH 5, Rajahmundry 533 294, India
    Contraception 74:148-56. 2006
    ..A controlled-release drug delivery of contraceptive steroids levonorgestrel (LNG) and ethinyl estradiol (EE) has been developed by successful encapsulation of LNG and EE in poly (lactide-co-glycolide) (PLG) microspheres...
  83. ncbi Preparation of uniform biodegradable microparticles using laser ablation
    Baojun Xie
    Vaxdesign Inc, Orlando, FL 32826, USA
    Int J Pharm 325:194-6. 2006
    ..By choosing appropriate set of variables, monosized biodegradable microparticles with wide range of particle size may be prepared...
  84. ncbi Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum
    Daniel S Kohane
    Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
    J Biomed Mater Res A 77:351-61. 2006
    ..The effect of sterilization technique on the incidence of adhesion formation is also studied...
  85. ncbi Formulation and in-vitro characterization of retinoic acid loaded poly (lactic-co-glycolic acid) microspheres
    Yasemin Cirpanli
    Department of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey
    J Microencapsul 22:877-89. 2005
    ..The yield of microspheres ranged from 50-75% and the encapsulation efficiency was determined between 45-75%. In vitro release studies showed that atRA release from microspheres lasted for 11 days...
  86. ncbi Copolymerization of D,L-lactide and glycolide in supercritical carbon dioxide with zinc octoate as catalyst
    Rosario Mazarro
    Faculty of Chemistry, Department of Chemical Engineering, University of Castilla La Mancha, Ciudad Real, Spain
    J Biomed Mater Res B Appl Biomater 85:196-203. 2008
    ..The most outstanding result was found by varying the stirring rate, where particles forming agglomerates seem to be obtained at the greater agitation levels...
  87. ncbi Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study
    Yuan He
    Department of Ophthalmology, Third Hospital, Peking University, Beijing, Peoples Republic of China
    Invest Ophthalmol Vis Sci 47:3983-8. 2006
    ..CONCLUSIONS: CyS-PLGA-MS, displaying sustained intraocular release of CyS and showing advantages over CyS solution, may meet clinical needs more efficiently...
  88. ncbi Controlled drug release from a novel injectable biodegradable microsphere/scaffold composite based on poly(propylene fumarate)
    Diederik H R Kempen
    Tissue Engineering and Polymeric Biomaterials Laboratory, Department of Orthopedic Surgery, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, Minnesota 55905, USA
    J Biomed Mater Res A 77:103-11. 2006
    ..The novel injectable PPF-based microsphere/scaffold composites developed in this study are promising to serve as vehicles for controlled drug delivery for bone tissue engineering...
  89. ncbi Formulation and evaluation of sustained release microspheres of poly-lactide-co-glycolide containing tamoxifen citrate
    S Sehra
    Department of Pharmaceutical Sciences, Guru Jambheshwar Univeristy, Hisar, Haryana, India
    J Microencapsul 22:521-8. 2005
    ..Drug, polymer and PVA concentrations were varied to obtain optimum release profile for sustaining the action of drug...
  90. ncbi Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid)
    K Frauke Pistel
    Department of Pharmaceutics and Biopharmacy, Philipps-University, Ketzerbach 63, D-35032, Marburg, Germany
    J Control Release 73:7-20. 2001
    ..The in vitro cytotoxicity of PVAL-g-PLGA is comparable to PLGA and therefore, this new class of biodegradable polyesters has considerable potential for parenteral drug delivery systems...
  91. ncbi Development of a sustained-release system for perivascular delivery of dipyridamole
    Weiwei Zhu
    Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, 84108, USA
    J Biomed Mater Res B Appl Biomater 77:135-43. 2006
    ..In vivo release of dipyridamole from microspheres/ReGel exhibited a comparable release pattern to that seen in vitro. This injectable platform is a promising technique for sustained perivascular delivery of antiproliferative drugs...
  92. ncbi PLGA microspheres with high drug loading and high encapsulation efficiency prepared by a novel solvent evaporation technique
    Wenchao Bao
    School of Life Science and Technology, Shanghai Jiaotong University, China
    J Microencapsul 23:471-9. 2006
    ..The in-situ S/O/W process is particularly applicable to encapsulate peptides and low molecular weight proteins...
  93. ncbi About mean diameter and size distributions of poly(lactide-co-glycolide) (PLG) microspheres
    Nader S Berchane
    Department of Mechanical Engineering, Texas A and M University, College Station, TX 77843-3123, USA
    J Microencapsul 23:539-52. 2006
    ..This is directly relevant to the pharmaceutical industry where microspheres of specified mean diameter and size distribution are desirable...
  94. ncbi The influence of surfactant on PLGA microsphere glass transition and water sorption: remodeling the surface morphology to attenuate the burst release
    C Bouissou
    Department of Pharmacy, University of Bath, Bath, BA2 7AY, UK
    Pharm Res 23:1295-305. 2006
    ....
  95. ncbi Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory
    N S Berchane
    Department of Mechanical Engineering, Texas A and M University, College Station, TX, USA
    Int J Pharm 337:118-26. 2007
    ..The validated mathematical model can be used to predict small-molecule drug release from PLG microsphere populations...
  96. ncbi Controlled release from coated polymer microparticles embedded in tissue-engineered scaffolds
    Y Hu
    Bone Tissue-Engineering Center, Carnegie Mellon University, Pittsburgh, PA 15213, USA
    J Drug Target 9:431-8. 2001
    ..Growth factors or drugs could be incorporated into the microparticles resulting in a long-term, controlled release...
  97. ncbi A new delivery system for antisense therapy: PLGA microspheres encapsulating oligonucleotide/polyethyleneimine solid complexes
    Giuseppe De Rosa
    , , Group of Drug Targeting and Delivery of Poorly Stable Compounds, 5, , , France
    Int J Pharm 254:89-93. 2003
    ..The designed microspheres allow the encapsulation and slow release of oligonucleotide/PEI solid complexes that should be effectively internalized inside cells...
  98. ncbi Biodegradable microparticles for the controlled delivery of oligonucleotides
    G De Rosa
    UMR CNRS 8612, , , , 92296, Chatenay-Malabry, France
    Int J Pharm 242:225-8. 2002
    ..The developed strategy appears to be a very interesting tool to obtain a sustained release system for oligonucleotides with an efficient cellular delivery...
  99. ncbi Fabrication of multi-layered biodegradable drug delivery device based on micro-structuring of PLGA polymers
    Won Hyoung Ryu
    Rapid Prototyping Laboratory, Mechanical Engineering Department, Stanford University, Rm 226, Bldg 530, 440 Escondido Mall, Stanford, CA 94305, USA
    Biomed Microdevices 9:845-53. 2007
    ..Comparison of the experiments to the simulated results identified that the variation of micro-geometry influenced also the volume-dependent degradation rate and induced the osmotic pressure...
  100. ncbi Biodegradable nanoparticles for cytosolic delivery of therapeutics
    Jaspreet K Vasir
    Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Adv Drug Deliv Rev 59:718-28. 2007
    ....
  101. ncbi Macromolecule release from monodisperse PLG microspheres: control of release rates and investigation of release mechanism
    Cory Berkland
    Department of Chemical and Biomolecular Engineering, University of Illinois, Urbana, Illinois 61801, USA
    J Pharm Sci 96:1176-91. 2007
    ..Monodisperse microspheres may represent a new delivery system for therapeutic proteins and DNA and provide enhanced control of delivery rates using simple injectable depot formulations...

Research Grants67

  1. Engineered Cartilage Storage and Transport Solution
    Kelvin Brockbank; Fiscal Year: 2005
    ..TECCS will be manufactured using polyglycolic acid felt and human chondrocytes...
  2. A COMPARISON OF IN VIVO AND VITRO TISSUE ENGINEERING
    Bradley Kropp; Fiscal Year: 2004
    ..cell cultures from the host's native bladder and has shown promise for use with membranes fabricated from polyglycolic acid polymers (PAP)...
  3. VITRIFICATION FOR TISSUE ENGINEERED BLOOD VESSELS
    Ying Song; Fiscal Year: 2005
    ..ice-free cryopreservation, known as vitrification, can have a salutary effects on the cryopreservation of polyglycolic acid - derived engineered vessels containing smooth muscle cells which otherwise sustain significant injury from ..
  4. TISSUE ENGINEERING OF PULMONARY VALVES AND PULMONARY ART
    John Mayer; Fiscal Year: 2002
    ..The TE structures created using polyglycolic acid polymer have poor surgical handling characteristics...
  5. Functionally Graded Scaffolds for Tissue Engineering
    Suman Das; Fiscal Year: 2004
    ..will be fabricated using a selective laser sintering machine with powder materials including polylactic acid-polyglycolic acid copolymers (PLGA), and PLGA-Hydroxyapatite (HA) composites with different volume fractions of HA in the PLGA ..
  6. Formulation & Evaluation of Bioadhesive Gels for Oral Cancer Chemoprevention
    Susan Mallery; Fiscal Year: 2006
    ..These studies will design and test bioadhesive gels that contain naturally derived cancer fighting compounds in human volunteers to determine the gels' abilities to effectively deliver the cancer preventing agents to the mouth tissues. ..
  7. Role of Oxidants & Angiogenesis in Kaposi's Sarcoma
    Susan Mallery; Fiscal Year: 2007
    ..Elucidation of these interactions will not only clarify KS pathogenic mechanisms, but will also identify sites for KS therapeutic intervention. ..
  8. Periodontal Engineering Using Biomimetic Nano Scaffolds
    Peter Ma; Fiscal Year: 2006
    ..abstract_text> ..
  9. Orchestrating Bone Regeneration on Multiple Scales
    Peter Ma; Fiscal Year: 2007
    ..SA 3. Confirm that the multi-scaled and factor-releasing scaffolds (selected from Aims 1&2) afford a superior environment for vascularized bone regeneration in a rat critical defect model. ..
  10. Nano Fibers for ADME/Toxicology
    Peter Ma; Fiscal Year: 2007
    ....
  11. Nanoparticle targeting of ICAM-1 as a potential treatment for Rheumatoid Arthriti
    Cory Berkland; Fiscal Year: 2007
    ..Here, we propose a potentially more selective approach for treating RA by attempting to localize drugs to molecular markers of inflammation (ICAM-1) as an alternative to systemic immunosuppression. ..
  12. Orchestrating Bone Regeneration on Multiple Scales
    Peter Ma; Fiscal Year: 2009
    ..SA 3. Confirm that the multi-scaled and factor-releasing scaffolds (selected from Aims 1&2) afford a superior environment for vascularized bone regeneration in a rat critical defect model. ..
  13. Chemoprevention of Oral Dysplasia by Black Raspberries
    Susan Mallery; Fiscal Year: 2005
    ..This experimental design (comparison of pretreatment and post-treatments tissues) permits each patient to serve as their own internal control. ..
  14. Chemoprevention of Head & Neck Cancer Using Controlled Release Polymers
    Susan R Mallery; Fiscal Year: 2011
    ....
  15. Periodontal Engineering Using Biomimetic Nano Scaffolds
    Peter Ma; Fiscal Year: 2009
    ..This project should significantly advance our capacity to design a modality for restoring periodontal wounds resulted from periodontitis, leading to advanced new regenerative therapies. ..
  16. Periodontal Engineering Using Biomimetic Nano Scaffolds
    Peter X Ma; Fiscal Year: 2010
    ..This project should significantly advance our capacity to design a modality for restoring periodontal wounds resulted from periodontitis, leading to advanced new regenerative therapies. ..
  17. Orchestrating Bone Regeneration on Multiple Scales
    Peter X Ma; Fiscal Year: 2010
    ..SA 3. Confirm that the multi-scaled and factor-releasing scaffolds (selected from Aims 1&2) afford a superior environment for vascularized bone regeneration in a rat critical defect model. ..
  18. Biomimetic Nano Scaffolds
    Peter Ma; Fiscal Year: 2004
    ..This knowledge will enable us to develop a predictable biomimetic scaffold for in vivo application and will be the basis for our planned R01 investigation. ..
  19. Chemoprevention of Head & Neck Cancer Using Controlled Release Polymers
    Susan R Mallery; Fiscal Year: 2010
    ....
  20. Periodontal Engineering Using Biomimetic Nano Scaffolds
    Peter Ma; Fiscal Year: 2009
    ..This project should significantly advance our capacity to design a modality for restoring periodontal wounds resulted from periodontitis, leading to advanced new regenerative therapies. ..
  21. Insulin Producing Cells from Amniotic Stem Cells for Diabetes Therapy
    Anthony Atala; Fiscal Year: 2009
    ..Successful development of an abundant source of transplantable insulin producing cells potentially would have a profound impact on the treatment of a major public health problem. ..
  22. Recognition of Mtb-infected cells by CD8+ T lymphocytes
    David M Lewinsohn; Fiscal Year: 2010
    ..AIM 2: Establish whether or not the Mtb-phagosome is a competent antigen processing organelle AIM 3: Characterize Mtb-reactive alpha beta TCR expressing thymocytes ..
  23. Mechanisms of In-Vivo Remodeling in Tissue Engineered Heart Valves
    Michael Sacks; Fiscal Year: 2007
    ..Relevance to public health includes the develop of valved pulmonary conduits for the pediatric population that can grow with the patient, minimizing the need for continued re-operations to bring the patient to adulthood. ..
  24. MYOCARDIAL CONTROLLED RELEASE IMPLANTS FOR ARRHYTHMIAS
    Robert Levy; Fiscal Year: 2001
    ..Plasmid DNA delivery will be achieved using sustained release nanoparticles formulated from polylactic-polyglycolic acid (PLGA), with co-incorporated poly-L- lysine(PLL) to enhance DNA delivery...